Claude Maraoui - Aug 25, 2025 Form 4 Insider Report for Journey Medical Corp (DERM)

Role: President & CEO, Director
Signature: /s/ Ramsey Alloush, attorney-in-fact
Stock symbol: DERM
Transactions as of: Aug 25, 2025
Transactions value $: -$1
Form type: 4
Date filed: 8/26/2025, 09:54 PM
Previous filing: Jun 20, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Maraoui Claude	President & CEO, Director	C/O JOURNEY MEDICAL CORPORATION, 9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE	/s/ Ramsey Alloush, attorney-in-fact	2025-08-26	0001893880

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DERM	Common Stock, $0.0001 par value	Options Exercise	$81.3K	+1.25M	+108.92%	$0.07	2.4M	Aug 25, 2025	Direct	F1
transaction	DERM	Common Stock, $0.0001 par value	Tax liability	-$81.3K	-10.9K	-0.45%	$7.47	2.39M	Aug 25, 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DERM	Stock Option (Right to Buy)	Options Exercise	$0	-1.25M	-100%	$0.00	0	Aug 25, 2025	Common Stock, $0.0001 par value	1.25M	$0.07	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Due to administrative error, the number of non-derivative securities beneficially owned by the reporting person was incorrectly reported as 2,397,590 instead of 1,147,590 on a Form 4 filed on June 20, 2025. This column reflects the corrected balance, as effected by the transactions reported on this Form 4.
F2	On October 19, 2015, the reporting person was granted 1,250,000 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that vested in accordance with the following schedule: 412,500 shares on January 7, 2016, 250,000 shares on September 22, 2016, 337,500 shares on January 7, 2017 and 250,000 shares on September 22, 2017. The 1,250,000 stock options are due to expire on October 19, 2025. Accordingly, the reporting person is exercising the stock options within the 60 days prior to the expiration date.

Content

Due to administrative error, the number of non-derivative securities beneficially owned by the reporting person was incorrectly reported as 2,397,590 instead of 1,147,590 on a Form 4 filed on June 20, 2025. This column reflects the corrected balance, as effected by the transactions reported on this Form 4.

On October 19, 2015, the reporting person was granted 1,250,000 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that vested in accordance with the following schedule: 412,500 shares on January 7, 2016, 250,000 shares on September 22, 2016, 337,500 shares on January 7, 2017 and 250,000 shares on September 22, 2017. The 1,250,000 stock options are due to expire on October 19, 2025. Accordingly, the reporting person is exercising the stock options within the 60 days prior to the expiration date.